Samjin Pharm

Samjin Pharmaceuticals Co., Ltd. manufactures and sells medicines in oral, drop, and injectable forms. Its over-the-counter products include Gevorin, an anti-inflammatory pain killer; Trestan, an appetite stimulant; Flaris, an anti-thrombotic agent; and Nutilin, a brain function improvement agent, as well as treatments for chronic diseases. The company is developing SA001 in Phase II trials for dry eye syndrome and Sjogren syndrome; SJP1804 in Phase I for macular degeneration; SJP1604 in Phase I for cancer; SJP1901 and SJP1902 for cancer; SJP1801 for Alzheimer's and Parkinson's disease; SJP006, an anti-viral product; and SJP003 for diabetes. Its preclinical product is SJP1602 for cancer. Founded in 1968, Samjin Pharmaceuticals is headquartered in Seoul, South Korea.